Carole Ho
2016
In 2016, Carole Ho earned a total compensation of $1M as Chief Medical Officer at Denali Therapeutics.
Compensation breakdown
| Bonus | $138,250 |
|---|---|
| Option Awards | $495,600 |
| Salary | $395,000 |
| Total | $1,028,850 |
Ho received $495.6K in option awards, accounting for 48% of the total pay in 2016.
Ho also received $138.3K in bonus and $395K in salary.
Rankings
In 2016, Carole Ho's compensation ranked 8,117th out of 14,075 executives tracked by ExecPay. In other words, Ho earned more than 42.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,117 out of 14,075 | 42nd |
Division Manufacturing | 3,102 out of 5,489 | 44th |
Major group Chemicals And Allied Products | 1,033 out of 1,895 | 46th |
Industry group Drugs | 803 out of 1,538 | 48th |
Industry Biological Products, Except Diagnostic Substances | 143 out of 279 | 49th |
Source: SEC filing on April 26, 2018.
Ho's colleagues
We found three more compensation records of executives who worked with Carole Ho at Denali Therapeutics in 2016.
News
Denali Therapeutics CEO Ryan Watts' 2021 pay jumps 36% to $13M
April 19, 2022
Denali Therapeutics CEO Ryan Watts' 2020 pay jumps 87% to $9.3M
April 22, 2021
Denali Therapeutics CEO Ryan Watts' 2019 pay slips 17% to $5M
April 22, 2020
Denali Therapeutics CEO Ryan Watts' 2018 pay jumps 338% to $6M
April 18, 2019